Brasília – The use of digital tools for diabetes monitoring and management is advancing in Brazil, driven by the adoption of insulin pumps, continuous glucose sensors, and real-world data analysis. According to Futuro da Saúde — in content sponsored by Hospital Israelita Albert Einstein — these technologies are transforming care by providing real-time information to patients and healthcare professionals, improving treatment control and adherence.

A study involving 12,000 participants revealed that 86.5% still rely on traditional finger-prick glucose testing, while only a small fraction use sensor-based devices. Experts note that the main barriers to adoption remain the high cost of sensors — which can cost around R$ 300 and require replacement every two weeks — and low digital literacy, particularly among older or low-income patients.

“Diabetes is a condition that requires intensive self-care,” said Karla Espírito Santo, cardiologist and Head of Studies at Hospital Israelita Albert Einstein. “These technologies were designed to empower patients, but access and knowledge gaps still limit their potential.” The article also points to future advances, such as long-lasting implantable sensors and artificial intelligence tools capable of detecting diabetes risk through voice analysis.

Source: Futuro da Saúde